Use of HIV protease inhibiting compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 14, 2003
Grant Date -
N/A
app pub date -
Jun 19, 2001
filing date -
Jun 11, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to the use of at least one compound that inhibits HIV (human immunodeficiency virus) protease, selected from ritonavir, saquinavir or one of the pharmaceutically acceptable salts thereof, in association with a pharmaceutically acceptable vehicle for the production of a medicament to modulate proteasome.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully